Esophageal cancer epidemiology and demographics

Revision as of 20:00, 20 December 2017 by Hadeel Maksoud (talk | contribs)
Jump to navigation Jump to search

Esophageal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Esophageal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal cancer epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal cancer epidemiology and demographics

CDC on Esophageal cancer epidemiology and demographics

Esophageal cancer epidemiology and demographics in the news

Blogs on Esophageal cancer epidemiology and demographics

Directions to Hospitals Treating Esophageal cancer

Risk calculators and risk factors for Esophageal cancer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]

Overview

Esophageal cancer is the 6th leading cause of death from cancer and the 8th most common cancer in the world. The prevalence of esophageal cancer worldwide is about 3.5 per 100,000. In the United States, about 17000 new cases are diagnosed every year and 4.45 per 100,000 Americans has esophageal cancer. Esophageal cancer is mostly present in the "Asian belt" region which includes, China, Japan, India and Iran.

Epidemiology and Demographics

Worldwide, the predominant type of esophageal cancer is squamous cell carcinoma. However, the rate of adenocarcinoma outnumbers squamous cell carcinoma in the United States and some European countries.[1]

Incidence

  • The incidence of esophageal cancer is approximately 3.5 per 100,000 individuals worldwide.
  • The age-adjusted incidence of invasive esophageal cancer was 4.2 per 100,000 individuals in the United States.
  • The American Cancer Society estimated that there are 16,960 new cases of esophageal cancer in the United States in 2017.

Prevalence

  • In 2014, the prevalence of esophageal cancer was estimated to be 7.25 cases per 100,000 individuals in the United States.


Case-fatality rate/Mortality rate

  • Between 2010 -2014, the incidence of esophageal cancer in the United States is approximately 4.2 per 100,000 individuals with a case-fatality rate/mortality rate of 4.1 per 100,000 individuals.

Age

  • The incidence of esophageal cancer increases with age; the median age at diagnosis is 50 years.[2]
  • The risk of esophageal cancer increases with age.
  • The age-adjusted incidence of invasive esophageal cancer worldwide by age category is:
    • Under 65 years: 1.8 per 100,000
    • 65 and over: 22.5 per 100,000

Race

  • Esophageal adenocarcinoma usually affects individuals of the Caucasian race. Black individuals are more likely to develop squamous cell carcinoma.[3]

dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24039351 }} </ref>

  • In the United States, 68.5% of caucasian subjects with esophageal cancer had adenocarcinoma, whereas 80% of black individuals affected with esophageal cancer had squamous cell carcinoma.

Gender

  • [Disease name] affects men and women equally.
  • [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • The prevalence of esophageal cancer differs among countries. In fact, esophageal cancer is most common in the area of the “Asian belt” which includes China, Japan, India, Iran, Turkey, among other Middle Eastern countries.[4]
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

Developing Countries

Gender

  • In the United States, the age-adjusted prevalence of invasive esophageal cancer by gender in 2011 is:[2]
    • In males: 0.0147%
    • In females: 0.0036%
  • In the United States, the delay-adjusted incidence of invasive esophageal cancer by gender in 2011 is:[2]
    • In males: 7.83 per 100,000 persons
    • In females: 1.83 per 100,000 persons




References

  1. Zhang Y (2013). "Epidemiology of esophageal cancer". World J Gastroenterol. 19 (34): 5598–606. doi:10.3748/wjg.v19.i34.5598. PMC 3769895. PMID 24039351.
  2. 2.0 2.1 2.2 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
  3. Siegel RL, Miller KD, Jemal A (2017). "Cancer Statistics, 2017". CA Cancer J Clin. 67 (1): 7–30. doi:10.3322/caac.21387. PMID 28055103.
  4. Pennathur A, Gibson MK, Jobe BA, Luketich JD (2013). "Oesophageal carcinoma". Lancet. 381 (9864): 400–12. doi:10.1016/S0140-6736(12)60643-6. PMID 23374478.


Template:WikiDoc Sources